Key terms
About TEVA
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TEVA news
Yesterday
8:17am ET
J.P. Morgan Reaffirms Their Hold Rating on Teva Pharmaceutical (TEVA)
Yesterday
5:21am ET
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Zentalis Pharmaceuticals (ZNTL) and Paragon 28 (FNA)
Yesterday
4:25am ET
UBS Reaffirms Their Buy Rating on Teva Pharmaceutical (TEVA)
May 08
8:48am ET
Teva sees FY24 capital expenditures $500M
May 08
7:35am ET
Teva backs FY24 EPS view $2.20-$2.50, consensus $2.41
May 08
7:33am ET
Teva reports Q1 EPS 48c, consensus 51c
May 08
6:36am ET
Teva, Medincell report ‘positive’ results from Phase 3 trial of TEV-‘749
May 07
7:43am ET
Teva Pharmaceutical (TEVA) Gets a Buy from Barclays
May 06
7:01am ET
Options Volatility and Implied Earnings Moves This Week, May 06 – May 10, 2024
Apr 30
12:25pm ET
Teva call volume above normal and directionally bullish
Apr 30
10:13am ET
FTC expands patent listing challenges for drugs
Apr 30
5:19am ET
Alvotech, Teva to manufacture biosimilar to Humira for Quallent
Apr 22
7:15pm ET
Vanda Pharmaceuticals responds to U.S. Supreme Court denial of petition
Apr 19
6:14am ET
Alvotech signs agreement with Teva to bring Adalimumab-ryvk to U.S. market
Apr 19
6:13am ET
Alvotech signs agreement with Teva to bring Adalimumab-ryvk to U.S. market
Apr 18
4:23pm ET
Teva Pharmaceutical Revamps Financial Reporting Structure
Apr 16
5:32pm ET
Teva and Alvotech announce FDA approved SELARSDI injection
Apr 16
8:13am ET
Teva announces final results from the HD cohort study for Austedo at AAN
Apr 11
1:36pm ET
Pfizer (NYSE:PFE) Settlement Sends Shares Up Slightly
Apr 11
8:41am ET
Teva announces AJOVY study met all critical efficacy endpoints in China trial
Apr 07
6:31am ET
Teva presents eight studies from LAI schizophrenia research program
Apr 05
3:25am ET
Barclays Reaffirms Their Buy Rating on Teva Pharmaceutical (TEVA)
Apr 04
3:36pm ET
Teva put volume heavy and directionally bearish
Apr 04
8:39am ET
Teva Pharmaceuticals, mAbxience announce strategic global agreement
Apr 01
8:33am ET
Teva, Launch Therapeutics enter clinical collaboration agreement
Mar 08
9:40am ET
GE upgraded, Vail Resorts downgraded: Wall Street’s top analyst calls
Mar 08
7:10am ET
Teva upgraded to Neutral from Underweight at JPMorgan
Mar 04
9:27am ET
UBS confident in Teva’s continued growth trajectory
Feb 26
7:55am ET
Piper Sandler Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)
Feb 26
7:12am ET
Teva, Jiangsu Nhwa Pharmaceutical enter partnership
Feb 25
6:23am ET
Alvotech, Teva announce U.S. approval of SIMLANDI injection
No recent press releases are available for TEVA
TEVA Financials
Key terms
Ad Feedback
TEVA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TEVA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range